Corporate Events

Organo Corporation Presents at WEFTEC 2026, Sep-28-2026 . Venue: Ernest N. Morial Convention Center, New Orleans, Louisiana, United States.

Organo Corporation, ¥ 110., Cash Dividend, Sep-29-2026

Organo Corporation announced that they will report Q1, 2027 results on Aug 03, 2026

Organo Corporation reported earnings results for the full year ended March 31, 2026. For the full year, the company reported sales was JPY 177,654 million. Net income was JPY 28,401 million. Basic earnings per share from continuing operations was JPY 617.74.

Organo Corporation, 5 : 1, Stock Split or Significant Stock Dividend, Sep-29-2026

Organo Corporation, Annual General Meeting, Jun 26, 2026.

Organo Corporation, Board Meeting, May 13, 2026. Agenda: To consider and resolve to conduct a share split and partially amend the Articles of Incorporation in connection with the share split; and to transact other matters.

Organo Corporation, 2026 Earnings Call, May 14, 2026

Organo Corporation(TSE:6368) added to S&P Japan 500

Organo Corporation announced that they will report fiscal year 2026 results on May 13, 2026

Organo Corporation provided consolidated earnings guidance for the fiscal year ending March 31, 2026. For the year, the company expected net sales of JPY 175,000 million; operating profit of JPY 36,000 million; profit attributable to owners of parent of JPY 27,000 million and basic earnings per share of JPY 587.28.

Organo Corporation reported earnings results for the nine months ended December 31, 2025. For the nine months, the company reported sales was JPY 127,729 million compared to JPY 115,698 million a year ago. Net income was JPY 17,999 million compared to JPY 13,965 million a year ago. Basic earnings per share from continuing operations was JPY 391.51 compared to JPY 303.81 a year ago.

Organo Corporation expected to report Fiscal Year 2026 results on May 12, 2026. This event was calculated by S&P Global (Created on February 4, 2026).

Organo Corporation announced that they will report Q3, 2026 results on Feb 04, 2026

Organo Corporation revised consolidated earnings guidance for the fiscal year ending March 31, 2026. For the year, the company now expects net sales of JPY 175,000 million; operating profit of JPY 36,000 million; profit attributable to owners of parent of JPY 27,000 million and basic earnings per share of JPY 587.32 against previous guidance of net sales of JPY 175,000 million; operating profit of JPY 34,000 million; profit attributable to owners of parent of JPY 26,100 million and basic earnings per share of JPY 567.81. Reason for revision: In light of recent performance trends and other factors, the Company has revised the consolidated earnings forecasts, which were announced on August 4, 2025. Orders received are expected to exceed the previous forecast and amount to JPY 185,000 million (up 2.8% from the previous forecast), mainly due to the fact that orders for solutions projects are expected to remain strong. Net sales are expected to be in line with the initial forecast, but profits are expected to exceed the previously announced forecast, mainly due to efforts to improve profitability, along with profit margin improvements achieved through cost reductions.

Organo Corporation announced interim dividend for the fiscal year ending March 31, 2026, Payable on December 1, 2025 and revised dividend guidance for the fiscal year ending March 31, 2026. The company announced interim dividend of JPY 95.00 per share compared to JPY 71.00 per share a year ago. Total dividends: JPY 4,371 million. Record Date: September 30, 2025. Source of dividends:Retained earnings. For the year, the company now expects dividend of JPY 95.00 per share against previous guidance of JPY 85.00 per share. Reasons for revision:The Company treats the return of profits to shareholders as one of the Company’s important management agendas, and it strives to distribute profits in a way that reflects consideration of the Company’s revenue status, while adhering to a basic policy of providing stable and continuous dividends. Specifically, the Company’s goal is to continue to increase dividends while maintaining the dividend payout ratio at 30% or more, with the aim of both expanding investment in growth and strengthening shareholder returns. Having given consideration to the above policy and recent performance trends, the Company has decided to pay interim dividends for the fiscal year ending March 31, 2026 of JPY 95 per share, which is an increase of JPY 10 per share from the latest projection. The Company has also revised the year-end dividends forecast to JPY 95, which is an increase of JPY 10 per share from the latest projection. As a result, the annual dividends for the fiscal year ending March 31, 2026 are projected to be JPY 190 per share (consolidated dividend payout ratio of 32.4%).

Organo Corporation, ¥ 95.0, Cash Dividend, Mar-30-2026

Organo Corporation expected to report Q3 2026 results on January 30, 2026. This event was calculated by S&P Global (Created on October 31, 2025).

Organo Corporation, Board Meeting, Oct 31, 2025. Agenda: To consider and approve to pay dividend of surplus with a record date of September 30, 2025 and revised the year-end dividends; and to consider any other matters.